

INFevo
Builds virtual-cell models (OCOO; OCOO-T predicts how a cell's gene expression changes under a drug, a gene knockdown or a cytokine), a hypothesis engine (The Popper Project) and a research workbench, run in a loop with its own automated lab for cell culture, perturbation and omics; incubated by XtalPi.
Money and evidence
No research by this company is on the record yet.
Rounds and research, on one timeline
- 2026-11-16Pre-ARound
over 100 million yuan
For: base-model R&D, a larger high-throughput automated wet-dry lab loop, and industry partnerships
Models and platformWet labAutomated lab
36Kr's first report, with the company's statements, read on 36Kr's NetEase account; 36Kr says the investors invested jointly and names no lead. The 36Kr report names Lipeng Lai as a co-founder of INFevo; that he is XtalPi's co-founder of that name is the record's reading, as XtalPi incubated the company.
Xinglian CapitalProsperity7 (Aramco)Huagai CapitalT-CapitalDT Capital PartnersExisting investor · Shunwei Capital
Existing investor · HSG (Sequoia China)Existing investor · Green Pine Capital Partners - 2026-06-01AngelRound
tens of millions of yuan
Not stated
Announced by XtalPi, the incubator; the three investors 'took part together', none named as lead. XtalPi's 2026 interim results repeat the round.
Shunwei Capital
HSG (Sequoia China)Green Pine Capital Partners
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
Its investors also backed
Other companies on this page whose rounds name the same investor.
- HSG (Sequoia China)Anew Labs, MoleculeMind, METiS TechBio, Insilico Medicine, TensorWorld
- Xinglian CapitalBioGeometry, AIPher
- Prosperity7Insilico Medicine
- T-CapitalDeep Principle